Antazoline phosphate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C17H19N3.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VPR5FPH326, chemically known as 1h-imidazole-2-methanamine, 4,5-dihydro-n-phenyl-n-(phenylmethyl)-, phosphate (1:1) but more generally known as antazoline phosphate, which bears US NIH Compound Identifier 158798. European Medicines Agency schedules Antazoline phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00541MIG. Most nations, for tariff and trade purposes, schedule antazoline phosphate under HS 29332990 and SITC 51573. As of Q4 2014, ANTAZOLINE PHOSPHATE remains US FDA's Preferred Term for this commodity. Antazoline phosphate bears US NLM identifiers UMLS ID C0003144 and NCI Concept Code C47399. SMILES: C1CCC(CC1)CN(CC2=NCCN2)C3CCCCC3.OP(=O)(O)O.